The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: Futura Medical to raise GBP12 million to fund clinical study

Fri, 14th May 2021 17:20

Futura Medical PLC - Surrey-based pharmaceutical company - Plans to raise GBP10 million in placing of shares at a price of 40 pence each, reflecting a discount of 21% to the company's closing price of 50.40 pence on Thursday.

Will also raised up to GBP2 million through a retail offer via the PrimaryBid platform at the same issue price.

Proceeds from the fundraising will go towards funding the small confirmatory clinical study required for the US FDA regulatory submission for MED3000 as a DeNoco medical device, as well as scale up its manufacturing activities, enabling lower costs for market launches.

Current stock price: 44.00 pence, down 13% on Friday

Year-to-date change: up sharply from 15.25p

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
10 Apr 2024 10:49

Futura Medical hails results as erectile dysfunction drug drives sales

(Alliance News) - Futura Medical PLC on Wednesday celebrated its "first set out meaningful revenues" in 2023, as sales for its erectile dysfunction tr...

3 Apr 2024 12:58

UK earnings, trading statements calendar - next 7 days

14 Feb 2024 09:24

IN BRIEF: Futura Medical's Eroxon to soon be available on prescription

Futura Medical PLC - Guildford, England-based pharmaceutical company focused on sexual health products - Confirms that lead product Eroxon will from M...

6 Feb 2024 17:04

LONDON MARKET CLOSE: BP and Prudential help snap FTSE losing streak

(Alliance News) - Stock prices in London pushed higher on Tuesday, with the FTSE 100 registering its first rise in four trading days, with oil major B...

6 Feb 2024 12:24

Futura Medical shares surge after "transformational year"

(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.